Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-08-22

FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Teva's original generic application for levocetirizine dihydrochloride, enabling market entry for this antihistamine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

ORIG AP for LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINE DIHYDROCHLORIDE)